Track topics on Twitter Track topics that are important to you
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Our research and development efforts are focused on anti-angiogenesis, obesity, infectious and respiratory diseases. We were incorporated in the State of Delaware in 1987 as Magainin Pharmaceuticals, Inc. and began operations in 1988. We changed our name to Genaera Corporation on March 9, 2001. Genaera maintains its headquarters and laboratory facilities in Plymouth Meeting, Pennsylvania.
5110 Campus Drive
United States of America
Phone: (610) 941-4020
Fax: (610) 941-5399
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Our research and development efforts are focused on anti-a...
Genaera Corporation has developed trodusquemine (MSI-1436) for type 2 diabetes and obesity and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma.
Addison Whitney is a strategic branding consultancy that specializes in the pharmaceutical industry. With over ten years' experience in pharmaceutical branding, our strategic offerings include: * ...
We have published hundreds of Genaera news stories on BioPortfolio along with dozens of Genaera Clinical Trials and PubMed Articles about Genaera for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genaera Companies in our database. You can also find out about relevant Genaera Drugs and Medications on this site too.
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...